KOTRA logo

Kotra Industries Berhad Stock Price

KLSE:KOTRA Community·RM 627.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

KOTRA Share Price Performance

RM 4.23
-0.01 (-0.24%)
RM 4.23
-0.01 (-0.24%)
Price RM 4.23

KOTRA Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet and fair value.

1 Risk
3 Rewards

Kotra Industries Berhad Key Details

RM 230.8m

Revenue

RM 60.6m

Cost of Revenue

RM 170.2m

Gross Profit

RM 127.7m

Other Expenses

RM 42.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
0.29
73.73%
18.40%
0.5%
View Full Analysis

About KOTRA

Founded
1982
Employees
635
CEO
Teck Piong
WebsiteView website
www.kotrapharma.com

Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. The company provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and senior citizens. It also offers various pharmaceutical products in the areas of pediatric care, anti-infective, gastroenterology, and dermatology under the Axcel brand; sterile antibiotic injectables under the Vaxcel brand; asthma control products under the Arite brand; and fungal infection treatment products under the Creobic brand. In addition, it provides treatment of pain, such as fever, migraine, joint pain, headache, and backpain under the AxPain brand. The company was founded in 1982 and is headquartered in Malacca, Malaysia. Kotra Industries Berhad is a subsidiary of Piong Nam Kim Holdings Sdn. Bhd.

Recent KOTRA News & Updates

Recent updates

No updates